Publication & Citation Trends
Publications
22 total
Evidence that a neutrophil–keratinocyte crosstalk is an early target of <scp>IL</scp>‐17A inhibition in psoriasis PDF
Cited by 199
OpenAlex
A Randomized, Placebo-Controlled Study of SRT2104, a SIRT1 Activator, in Patients with Moderate to Severe Psoriasis PDF
Cited by 101
OpenAlex
Guselkumab (an IL-23–specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis PDF
Cited by 298
OpenAlex
Efficacy, tolerability, and pharmacodynamics of apremilast in recalcitrant plaque psoriasis: a phase II open-label study.
Cited by 77
OpenAlex
Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis PDF
Cited by 929
OpenAlex
Efficacy of apremilast in the treatment of moderate to severe psoriasis: a randomised controlled trial
Cited by 279
OpenAlex
Safety profile of intravenous and subcutaneous siplizumab, an anti‐CD2 monoclonal antibody, for the treatment of plaque psoriasis: results of two randomized, double‐blind, placebo‐controlled studies
Cited by 26
OpenAlex
Topical Methyl Aminolevulinate Photodynamic Therapy Using Red Light-Emitting Diode Light for Multiple Actinic Keratoses
Cited by 87
OpenAlex
Research Topics
Psoriasis: Treatment and Pathogenesis
(15)
Dermatology and Skin Diseases
(8)
Spondyloarthritis Studies and Treatments
(6)
Nonmelanoma Skin Cancer Studies
(4)
Cutaneous Melanoma Detection and Management
(3)
Affiliations
Oregon Health & Science University
University of Utah
Oregon Medical Research Center